Evan Miller

Dr. Evan Miller

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2015 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YHYi-Lin Huang
Yi-Lin Huang
AWAlison S. Walker
Alison S. Walker
EMEvan Miller
Evan Miller

29 July 2019 in Nature Methods
Verified
Journal Article
Closed access
PDF file
AKAbbas Kazemipour
Abbas Kazemipour
ONOndrej Novak
Ondrej Novak
DFDaniel Flickinger
Daniel Flickinger
JMJonathan S. Marvin
Jonathan S. Marvin
AAAhmed S. Abdelfattah
Ahmed S. Abdelfattah
KPKaspar Podgorski
Kaspar Podgorski

29 February 2020 in Journal of the American Chemical Society
Verified
Journal Article
Open access
DKDnyaneshwar Kand
Dnyaneshwar Kand
PLPei Liu
Pei Liu
MNMarisol X. Navarro
Marisol X. Navarro
LFLogan J. Fischer
Logan J. Fischer
LRLiat Rousso-Noori
Liat Rousso-Noori
RWRoy Weinstain
Roy Weinstain
Photoactivation of bioactive molecules allows manipulation of cellular processes with high spatio-temporal precision. The recent emergence of visible-light excitable photoprotecting groups has the potential to further expand the established utility of the photoactivation strategy in biological applications by offering higher tissue penetration, dimin-ished phototoxicity, and compatibility with other light-dependent techniques. Nevertheless, a critical barrier to such applications remains the significant hydrophobicity of most visible-light excitable photocag-ing groups. Here, we find that applying the conventional 2,6-sulfonation to meso-methyl BODIPY photocages is incompatible with their photoreaction due to an increase in the excited state barrier for photorelease. We present a simple, remote sulfonation solution to BODIPY photocages that imparts water solubility and provides con-trol over cellular permeability while retaining their favorable spectro-scopic and photoreaction properties. Peripherally disulfonated BODIPY photocages are cell impermeable, making them useful for modulation of cell-surface receptors, while mono-sulfonated BODIPY retain the ability to cross the cellular membrane and can modulate intracellular targets. This new approach is generalizable for controlling BODIPY localization, and was validated by sensitization of mammalian cells and neurons by visible-light photoactivation of signaling molecules.

29 January 2015 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CWClifford R. Woodford
Clifford R. Woodford
EFE. Paxon Frady
E. Paxon Frady
RSRichard S. Smith
Richard S. Smith
BMBenjamin Morey
Benjamin Morey
GCGabriele Canzi
Gabriele Canzi
RTRoger Y. Tsien
Roger Y. Tsien

31 March 2023 in Science
Verified
Journal Article
Closed access
PHPavel Hanč
Pavel Hanč
RGRodrigo J. Gonzalez
Rodrigo J. Gonzalez
IMIrina B. Mazo
Irina B. Mazo
YWYidi Wang
Yidi Wang
TLTalley Lambert
Talley Lambert
UAUlrich H. von Andrian
Ulrich H. von Andrian
It is known that interactions between nociceptors and dendritic cells (DCs) can modulate immune responses in barrier tissues. However, our understanding of the underlying communication frameworks remains rudimentary. Here, we show that nociceptors control DCs in three molecularly distinct ways. First, nociceptors release the calcitonin gene–related peptide that imparts a distinct transcriptional profile on steady-state DCs characterized by expression of pro–interleukin-1β and other genes implicated in DC sentinel functions. Second, nociceptor activation induces contact-dependent calcium fluxes and membrane depolarization in DCs and enhances their production of proinflammatory cytokines when stimulated. Finally, nociceptor-derived chemokine CCL2 contributes to the orchestration of DC-dependent local inflammation and the induction of adaptive responses against skin-acquired antigens. Thus, the combined actions of nociceptor-derived chemokines, neuropeptides, and electrical activity fine-tune DC responses in barrier tissues.

1 August 2016 in Current Opinion in Chemical Biology
Verified
Journal Article
Closed access
EMEvan Miller
Evan Miller